Cargando…

Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants

The global spread of COVID-19 is devastating health systems and economies worldwide. While the use of vaccines has yielded encouraging results, the emergence of new variants of SARS-CoV-2 shows that combating COVID-19 remains a big challenge. One of the most promising treatments is the use of not on...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Hung, Li, Mai Suan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188278/
https://www.ncbi.nlm.nih.gov/pubmed/35690632
http://dx.doi.org/10.1038/s41598-022-14263-1

Ejemplares similares